- Home
- SPCB vs KRON Comparison
SPCB vs KRON Comparison
Compare SPCB & KRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPCB
- KRON
- Stock Information
- Founded
- SPCB 1988
- KRON 2017
- Country
- SPCB Israel
- KRON United States
- Employees
- SPCB N/A
- KRON 8
- Industry
- SPCB Semiconductors
- KRON Medicinal Chemicals and Botanical Products
- Sector
- SPCB Technology
- KRON Health Care
- Exchange
- SPCB Nasdaq
- KRON Nasdaq
- Market Cap
- SPCB 53.3M
- KRON 54.1M
- IPO Year
- SPCB N/A
- KRON 2020
- Fundamental
- Price
- SPCB $10.55
- KRON $0.88
- Analyst Decision
- SPCB Strong Buy
- KRON Buy
- Analyst Count
- SPCB 1
- KRON 3
- Target Price
- SPCB $18.00
- KRON $1.63
- AVG Volume (30 Days)
- SPCB 190.1K
- KRON 1.4M
- Earning Date
- SPCB 08-14-2025
- KRON 08-07-2025
- Dividend Yield
- SPCB N/A
- KRON N/A
- EPS Growth
- SPCB N/A
- KRON N/A
- EPS
- SPCB 1.89
- KRON N/A
- Revenue
- SPCB $27,831,000.00
- KRON $9,192,000.00
- Revenue This Year
- SPCB $2.73
- KRON N/A
- Revenue Next Year
- SPCB $22.87
- KRON N/A
- P/E Ratio
- SPCB $5.44
- KRON N/A
- Revenue Growth
- SPCB 2.90
- KRON 21.16
- 52 Week Low
- SPCB $2.55
- KRON $0.65
- 52 Week High
- SPCB $18.95
- KRON $1.60
- Technical
- Relative Strength Index (RSI)
- SPCB 55.51
- KRON 65.76
- Support Level
- SPCB $9.66
- KRON $0.87
- Resistance Level
- SPCB $11.14
- KRON $0.90
- Average True Range (ATR)
- SPCB 0.89
- KRON 0.02
- MACD
- SPCB -0.14
- KRON 0.00
- Stochastic Oscillator
- SPCB 36.18
- KRON 53.86
About SPCB SuperCom Ltd. (Israel)
SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.
About KRON Kronos Bio Inc.
Kronos Bio Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of small molecule therapeutics to address deregulated transcription, a hallmark of cancer and autoimmune diseases.